vs

Side-by-side financial comparison of Ispire Technology Inc. (ISPR) and SANUWAVE Health, Inc. (SNWV). Click either name above to swap in a different company.

Ispire Technology Inc. is the larger business by last-quarter revenue ($20.3M vs $13.4M, roughly 1.5× SANUWAVE Health, Inc.). SANUWAVE Health, Inc. runs the higher net margin — 57.4% vs -32.5%, a 90.0% gap on every dollar of revenue. On growth, SANUWAVE Health, Inc. posted the faster year-over-year revenue change (30.3% vs -51.5%). SANUWAVE Health, Inc. produced more free cash flow last quarter ($3.2M vs $-4.0M). Over the past eight quarters, SANUWAVE Health, Inc.'s revenue compounded faster (53.5% CAGR vs -17.8%).

Ispire Technology Inc. is a global tech firm specializing in R&D, manufacturing and sales of advanced vaporization hardware and supporting consumables. It serves nicotine and legal cannabis consumer markets, operates two core segments of hardware and branded cannabis products, covers North America, Europe and Asia-Pacific, delivering compliant innovative vapor solutions for B2B partners and end users.

SANUWAVE Health, Inc. is a medical technology company specializing in non-invasive regenerative care solutions. It develops and commercializes shock wave therapy systems for treating chronic wounds, diabetic foot ulcers, and orthopedic conditions, serving healthcare providers and patients across North America, Europe, and key Asia-Pacific markets.

ISPR vs SNWV — Head-to-Head

Bigger by revenue
ISPR
ISPR
1.5× larger
ISPR
$20.3M
$13.4M
SNWV
Growing faster (revenue YoY)
SNWV
SNWV
+81.8% gap
SNWV
30.3%
-51.5%
ISPR
Higher net margin
SNWV
SNWV
90.0% more per $
SNWV
57.4%
-32.5%
ISPR
More free cash flow
SNWV
SNWV
$7.3M more FCF
SNWV
$3.2M
$-4.0M
ISPR
Faster 2-yr revenue CAGR
SNWV
SNWV
Annualised
SNWV
53.5%
-17.8%
ISPR

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
ISPR
ISPR
SNWV
SNWV
Revenue
$20.3M
$13.4M
Net Profit
$-6.6M
$7.7M
Gross Margin
17.1%
74.7%
Operating Margin
-33.9%
15.0%
Net Margin
-32.5%
57.4%
Revenue YoY
-51.5%
30.3%
Net Profit YoY
17.4%
157.8%
EPS (diluted)
$-0.12
$0.78

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ISPR
ISPR
SNWV
SNWV
Q4 25
$20.3M
$13.4M
Q3 25
$30.4M
$11.4M
Q2 25
$20.1M
$10.1M
Q1 25
$26.2M
$9.3M
Q4 24
$41.8M
$10.3M
Q3 24
$39.3M
$9.3M
Q2 24
$37.3M
$7.1M
Q1 24
$30.0M
$5.7M
Net Profit
ISPR
ISPR
SNWV
SNWV
Q4 25
$-6.6M
$7.7M
Q3 25
$-3.3M
$9.7M
Q2 25
$-14.8M
$551.0K
Q1 25
$-10.9M
$-6.1M
Q4 24
$-8.0M
$-13.3M
Q3 24
$-5.6M
$-21.2M
Q2 24
$-3.5M
$6.2M
Q1 24
$-5.9M
$-4.8M
Gross Margin
ISPR
ISPR
SNWV
SNWV
Q4 25
17.1%
74.7%
Q3 25
17.0%
76.6%
Q2 25
12.3%
77.3%
Q1 25
18.2%
79.4%
Q4 24
18.5%
78.2%
Q3 24
19.5%
76.1%
Q2 24
28.3%
74.0%
Q1 24
20.4%
73.9%
Operating Margin
ISPR
ISPR
SNWV
SNWV
Q4 25
-33.9%
15.0%
Q3 25
-8.9%
7.9%
Q2 25
-72.7%
14.2%
Q1 25
-40.4%
6.5%
Q4 24
-17.6%
19.6%
Q3 24
-13.4%
16.0%
Q2 24
-9.2%
23.3%
Q1 24
-18.8%
-22.8%
Net Margin
ISPR
ISPR
SNWV
SNWV
Q4 25
-32.5%
57.4%
Q3 25
-10.7%
84.8%
Q2 25
-73.4%
5.4%
Q1 25
-41.5%
-65.8%
Q4 24
-19.1%
-129.5%
Q3 24
-14.2%
-227.8%
Q2 24
-9.4%
87.4%
Q1 24
-19.7%
-84.4%
EPS (diluted)
ISPR
ISPR
SNWV
SNWV
Q4 25
$-0.12
$0.78
Q3 25
$-0.06
$0.39
Q2 25
$-0.26
$-0.04
Q1 25
$-0.19
$-0.72
Q4 24
$-0.14
$-0.76
Q3 24
$-0.10
$-6.65
Q2 24
$-0.07
$0.00
Q1 24
$-0.11
$0.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ISPR
ISPR
SNWV
SNWV
Cash + ST InvestmentsLiquidity on hand
$17.6M
$12.0M
Total DebtLower is stronger
$21.9M
Stockholders' EquityBook value
$-7.7M
$1.6M
Total Assets
$84.4M
$37.3M
Debt / EquityLower = less leverage
13.52×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ISPR
ISPR
SNWV
SNWV
Q4 25
$17.6M
$12.0M
Q3 25
$22.7M
$9.6M
Q2 25
$24.4M
$8.5M
Q1 25
$23.5M
$8.5M
Q4 24
$34.4M
$10.2M
Q3 24
$37.7M
$3.3M
Q2 24
$35.1M
$2.5M
Q1 24
$39.5M
$2.9M
Total Debt
ISPR
ISPR
SNWV
SNWV
Q4 25
$21.9M
Q3 25
$23.3M
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ISPR
ISPR
SNWV
SNWV
Q4 25
$-7.7M
$1.6M
Q3 25
$-1.8M
$-7.6M
Q2 25
$604.7K
$-18.8M
Q1 25
$14.8M
$-20.8M
Q4 24
$24.2M
$-15.8M
Q3 24
$30.7M
$-60.3M
Q2 24
$34.5M
$-39.6M
Q1 24
$35.9M
$-47.6M
Total Assets
ISPR
ISPR
SNWV
SNWV
Q4 25
$84.4M
$37.3M
Q3 25
$96.4M
$35.6M
Q2 25
$102.2M
$33.0M
Q1 25
$115.7M
$30.9M
Q4 24
$132.0M
$30.1M
Q3 24
$129.0M
$21.8M
Q2 24
$122.6M
$21.0M
Q1 24
$108.0M
$23.3M
Debt / Equity
ISPR
ISPR
SNWV
SNWV
Q4 25
13.52×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ISPR
ISPR
SNWV
SNWV
Operating Cash FlowLast quarter
$-4.0M
$3.3M
Free Cash FlowOCF − Capex
$-4.0M
$3.2M
FCF MarginFCF / Revenue
-19.9%
24.1%
Capex IntensityCapex / Revenue
0.3%
0.7%
Cash ConversionOCF / Net Profit
0.43×
TTM Free Cash FlowTrailing 4 quarters
$-14.2M
$1.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ISPR
ISPR
SNWV
SNWV
Q4 25
$-4.0M
$3.3M
Q3 25
$-1.2M
$1.1M
Q2 25
$4.7M
$993.0K
Q1 25
$-12.5M
$-1.5M
Q4 24
$-3.2M
$741.0K
Q3 24
$3.6M
$1.3M
Q2 24
$-1.4M
$-668.0K
Q1 24
$3.4M
$1.1M
Free Cash Flow
ISPR
ISPR
SNWV
SNWV
Q4 25
$-4.0M
$3.2M
Q3 25
$-1.2M
$556.0K
Q2 25
$3.7M
$-166.0K
Q1 25
$-12.7M
$-1.7M
Q4 24
$-3.2M
$505.0K
Q3 24
$3.3M
$1.2M
Q2 24
$-2.2M
$-760.0K
Q1 24
$3.3M
$986.0K
FCF Margin
ISPR
ISPR
SNWV
SNWV
Q4 25
-19.9%
24.1%
Q3 25
-3.9%
4.9%
Q2 25
18.6%
-1.6%
Q1 25
-48.4%
-18.1%
Q4 24
-7.7%
4.9%
Q3 24
8.5%
13.3%
Q2 24
-5.9%
-10.7%
Q1 24
10.9%
17.3%
Capex Intensity
ISPR
ISPR
SNWV
SNWV
Q4 25
0.3%
0.7%
Q3 25
0.0%
4.6%
Q2 25
4.8%
11.4%
Q1 25
0.7%
1.7%
Q4 24
0.1%
2.3%
Q3 24
0.7%
0.5%
Q2 24
2.0%
1.3%
Q1 24
0.3%
2.0%
Cash Conversion
ISPR
ISPR
SNWV
SNWV
Q4 25
0.43×
Q3 25
0.11×
Q2 25
1.80×
Q1 25
Q4 24
Q3 24
Q2 24
-0.11×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons